Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis
BackgroundThe efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain metastases in non-small cell lung cancer patients remains to be determined.MethodsA systematic search was conducted using dat...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2024-04-01
|
| Serija: | Frontiers in Neurology |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1362061/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|